Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

687 results about "RNA extraction" patented technology

RNA extraction is the purification of RNA from biological samples. This procedure is complicated by the ubiquitous presence of ribonuclease enzymes in cells and tissues, which can rapidly degrade RNA. Several methods are used in molecular biology to isolate RNA from samples, the most common of these is guanidinium thiocyanate-phenol-chloroform extraction. The filter paper based lysis and elution method features high throughput capacity.

Nucleic acid extraction and purification method based on nanometer magnetic beads and kit

The invention discloses a nucleic acid extraction and purification method based on nanometer magnetic beads, comprising the following steps: mixing a biological sample and a lysis buffer to make nanometer magnetic beads in the lysis buffer and nucleic acid DNA/RNA which moves into the lysis buffer form a magnetic bead-nucleic acid compound; transferring the compound under the action of a magnetic field to a washing buffer to wash off impurities on the magnetic bead-nucleic acid compound; and transferring the washed magnetic bead- nucleic acid compound under the action of the magnetic field to an elution buffer so as to elute and recover nucleic acid. The nanometer magnetic beads used in the invention have advantages of uniform size, smooth surface, large surface area ratio, high adsorption capacity of nucleic acid, fast magnetic response speed and rapid separation, and can be stored together with the lysis buffer at room temperature for a long time. The extracted nucleic acid DNA/RNA has high purity, is complete and can be directly used for follow-up detection. The method provided by the invention has shorter nucleic acid extraction time than a general magnetic bead method by the use of a nucleic acid extraction reagent, is more suitable for automation and is adopted to realize high-flux nucleic acid DNA/RNA extraction.
Owner:苏州天隆生物科技有限公司

Method and kit for extracting ribonucleic acid (RNA)

The invention relates to the field of molecular biology and discloses a method and a kit for extracting ribonucleic acid (RNA). The method for extracting the RNA comprises the following steps of: uniformly mixing a sample and lysis solution; centrifugally collecting supernate and uniformly mixing the supernate and absolute ethyl alcohol which is half of the volume of the supernate; combining the mixture with 0.45 mu m glass fiber cellulose acetate membrane; washing with deproteinization liquid and rinsing liquid; eluting adsorbed RNA; uniformly mixing lysis cells and an extraction aid; and centrifugally removing polysaccharide and polyphenol substances. The kit for extracting the RNA comprises the lysis solution, the deproteinization liquid, the rinsing liquid, the eluting liquid and the extraction aid. The method of the invention has the advantages of simpleness, rapidness, no use of toxic reagent, wide application range and capabilities of effectively removing the polysaccharide andpolyphenol substances and separating high-quality RNA out by adding the extraction aid. The kit of the invention has the advantages of no toxic reagent, wide application range, RNA extraction effectsof plant materials which are rich in polysaccharide and polyphenol superior to that of foreign kits, low cost and suitability for extensive laboratories and scientific researches.
Owner:中生方政生物技术股份有限公司

Silicon dioxide nanofiber membrane, and preparation method and application thereof

InactiveCN106939471ASimple processOvercoming the need to add directing agentsFilament/thread formingNon-woven fabricsRNA extractionSurface-active agents
The invention relates to the field of nanometer materials, and discloses a silicon dioxide nanofiber membrane, and a preparation method and application thereof. The method comprises the following steps: (1) preparing spinning solution containing nanosilicon dioxide, a surface active agent, a high-molecular polymer and solvent, and (2) processing the spinning solution prepared in step (1) by utilizing electrospinning technique, and drying to obtain the silicon dioxide nanofiber membrane, wherein the average grain diameter of the nanosilicon dioxide in step (1) ranges from 20nm to 120nm. The fiber diameters of the silicon dioxide nanofiber membrane which is prepared by the method provided by the invention range from 80nm to 600nm; the thickness is small; therefore, the bore diameter and specific surface area of the silicon dioxide nanofiber membrane are relatively large; the surface energy and surface activity are high; the silicon dioxide nanofiber membrane provided by the invention can be applied into an RNA (ribose nucleic acid) extraction kit adsorbing column, and has the advantages that the extraction scope and category are wide, the extraction is rapid, simple and convenient, the purification rate is high, and the ratio of performance to price is high.
Owner:MATERIAL & IND TECH RES INST BEIJING

BCR/ABL fusion gene mRNA fluorescence quantitative PCR detecting kit

The invention relates to a BCR / ABL fusion gene (P210bcr / abl) mRNA fluorescence quantitative PCR measurement detection reagent box which comprises lymphocyte segregating liquid, RNA extracting liquid A, RNA extracting liquid B, Oligo (dT) 12-18, RT reaction fluid, reverse transcriptase, quantitative PCR reaction fluid, standard sample, comparison sample, and DEPC water; wherein, a marked primer and a non-marked primer are contained in the quantitative PCR reaction fluid. The reagent box can accurately detect the BCR / ABL fusion gene (P210) mRNA level in the specimen to be detected by extracting the total RNA of medulla ossium or peripheral blood, obtaining cDNA through reverse transcriptase and being combined with a real-time fluorescence quantitative PCR measurement detection technology. The reagent box adopts the latest self-quenched probe technology, thereby having the advantages that the repetitiveness is good, the sensitivity is high, the cost is low, and the invention can be applied to the dynamic monitoring of chronic myelocytic leukemia diagnosis, curative effect observation, prognosis and micro residual leukemia (MRD).
Owner:冯文莉

Porcine reproductive and respiratory syndrome virus RT-LAMP detection kit and detection method thereof

The invention relates to a porcine reproductive and respiratory syndrome virus RT-LAMP detection kit and a detection method thereof. Primers required by PRSSV RT-LAMP reaction system are designed according to the sequence of porcine reproductive and respiratory syndrome virus (PRSSV) published by GenBank; PRSSV virus RNA is extracted with the virus RNA extraction reagent (LBBII-RNA) designed and prepared by the inventor, the PRSSV RT-LAMP reaction system established in the invention is utilized for detection, and color developing agent is added after the reaction to judge the result; the result shows that the PRSSV virus RNA obtains efficient specific amplification after the reaction is conducted for 45 minutes at the temperature of 63 DEG C; and then, quick detection of porcine reproductive and respiratory syndrome virus American classical strain and NSP2 variant strain (highly pathogenic porcine reproductive and respiratory syndrome virus strain) is conducted by SpuI enzyme cutting. Compared with the prior art, the invention has quick detection, high sensitivity, low reaction cost, convenient and fast operation, which is capable of differentiating American classical strain and NSP2 variant strain (highly pathogenic porcine reproductive and respiratory syndrome virus strain) and meets the requirement of multi-level detection.
Owner:CHINA INST OF VETERINARY DRUG CONTROL

Digital PCR-based novel coronavirus nucleic acid quantitative detection kit and application

The invention discloses a digital PCR-based novel coronavirus nucleic acid quantitative detection kit and an application. The reaction total system of the digital PCR-based novel coronavirus nucleic acid quantitative detection kit has 20 ul, comprising 10ul of 2x One-Step RT-ddPCR Supermix, 0.8ul of 25mM manganese acetate solution, 5ul of to-be-detected sample RNA, 1ul of ORFlab gene primer probeworking solution, 1ul of N gene primer probe working solution, 1ul of RPP30 gene primer probe working solution and 1.2ul of Nuclease-Free Water, wherein 5ul of negative control RNA extraction solutionand 5ul of positive control RNA extraction solution are adopted to replace the to-be-detected sample RNA in a negative control reaction system and a positive control reaction system respectively. Based on the innovative RNA one-step reverse transcription microdroplet type digital PCR technology, nucleic acid absolute quantification is carried out specific to highly conservative ORFlab gene and Ngene in the novel coronavirus (2019-nCoV) genome, so that the detection accuracy is improved, and the kit can be used for clinical assisted diagnosis and viral load analysis of novel coronavirus (2019-nCoV) infection, and has a wide clinical application value.
Owner:南京实践医学检验有限公司

Method and kit for detecting RV RNA (Rubella Virus Ribose Nucleic Acid)

The invention provides a method for extracting, purifying and detecting RV RNA (Rubella Virus Ribose Nucleic Acid), and a corresponding kit for detecting the RV RNA. The kit comprises a RNA extracting solution containing magnetic beads, and a PCR (Polymerase Chain Reaction) reaction liquid containing an upstream primer, a downstream primer and a probe, wherein the upstream primer and the downstream primer are used for amplifying target polynucleotides; the probe is used for detecting the target polynucleotides. The kit can be used for detecting the RV RNA and cannot be used for detecting non-RV pathogens, thereby illustrating that the kit has the good specificity. In addition, the RNA is extracted by selecting a method of the magnetic beads which are good in adsorption effect and easy to purify, so that the RNA with a high purity and a high yield can be obtained. Thus, the detection sensitivity, the detection accuracy and the detection stability of the kit are greatly improved, wherein the lower limit of detection of the RNA, namely, the sensitivity of the kit can reach 400copies / ml; the detection range of the kit (the quantitative linear range of the kit) can reach 4.00E+02copies / ml to 4.00E+08copies / ml.
Owner:SANSURE (SHANGHAI) GENE TECH LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products